New Guidewire for Crossing Resistant Lesions

Proprietary stainless steel core technology enables the wire to have superior torque, thus providing optimal steering and control. The Victory guidewires come in both 0.3556 mm and 0.4572 mm diameters with four different gram-load options--ranging from 12 g to 30 g--that offer clinical versatility and a range of pushability.

PAD, which is characterized by blockage or narrowing in vessels of the peripheral vasculature, is frequently associated with critical limb ischemia (CLI), a serious condition affecting an increasing number of patients worldwide. CLI patients have multivessel disease and challenging lesions, which, if left untreated, can lead to limb loss. In the United States alone, an estimated 25% of patients with PAD without treatment will require amputation within one year of onset of CLI. The Victory guidewire is a product of the Boston Scientific (Natick, MA, USA), and has been approved by the US Food and Drug Administration (FDA).

“Physicians treating CLI patients typically require a variety of treatment options. Boston Scientific is committed to offering a wide variety of crossing solutions,” said Jeff Mirviss, president of the Boston Scientific peripheral interventions division. “Victory guidewires complement our already broad portfolio of crossing solutions, inclusive of our market-leading angioplasty balloons, Rubicon Support Catheter, and the TruePath CTO device. The Victory guidewires offer another option to cross these highly resistant lesions and potentially avoid the need for amputation.”

“Resistant lesions can be a challenge and I often need various tools to access, cross and treat these types of lesions,” said interventional radiologist Derek Mittleider, MD, director of vascular and interventional radiology at Spectrum Medical Group (Portland, ME, USA). “The Victory wire's high gram-load options and excellent torque-ability give me the extra push and steer-ability I need to get through these resistant lesions more easily, making these cases less challenging.”

Related Links:
Boston Scientific